Navigation Links
Labopharm amends debt facility agreement with Hercules
Date:6/25/2009

structuring of the Canadian asset-backed commercial paper, which amount the Company can, under certain conditions, repay at maturity by delivering the notes to the bank.

About Labopharm Inc.

Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is now available in 17 countries around the world, including the U.S., Canada, major European markets, and Australia, among others. The Company's second product, a novel formulation of trazodone for the treatment of major depressive disorder, is under regulatory review by the FDA. The Company also has a robust pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products. For more information, please visit www.labopharm.com.

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors, including the uncertainties related to the regulatory process in various countries for the approval of the Company's products and the successful commercialization of the products throughout the world if they are approved. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.

'/>"/>

SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
2. Labopharm Reports Results for First Quarter Fiscal 2009
3. Labopharm announces details for first quarter results conference call and annual meeting
4. Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation
5. Labopharm to present at Cowen 29th Annual Health Care Conference
6. Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008
7. Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET)
8. Labopharm to host conference call to discuss FDA approval of once-daily RYZOLT(TM) on Tuesday, January 6, 2009 at 8:30 a.m. (ET)
9. Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain
10. Labopharm to host webcast presentation on novel trazodone formulation - tomorrow (Dec.16/08) at 10:00 a.m. ET
11. Labopharm Comments on Recent Trading Activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Dentists from throughout Canada tomorrow will ... Oxnard All-on-4™ dental implants expert and world-renowned ... Anacapa Dental Art Institute in Ventura County, Calif., ... Restorative Dentistry and Prosthodontics (CARDP) annual Scientific Meeting ... Augmentation: Esthetic Implant Supported Maxillary Prostheses,” is scheduled ...
(Date:9/18/2014)... Forty Fort, PA (PRWEB) September 18, 2014 ... remodeling display at the Bloomsburg Fair beginning this Saturday. ... The display is a great example of the products and ... three cabinet lines and various countertops for fair-goers to see. ... Home & Garden Show earlier this year and really is ...
(Date:9/18/2014)... 18, 2014 New discount dental plans ... find dentists and see exact plan savings in their area ... and have an immediate ID# to use the plan same ... there choosing the right plan can be difficult. With most ... exact plan savings and discounts in a particular zip code ...
(Date:9/18/2014)... NY (PRWEB) September 18, 2014 Computer ... solutions firm based in New York City, has been ... for a leading global retailer with stores in over ... central help desk with CRA being the retailer’s dispatch ... NYC office. , Chico Ramnarayan, Chief Executive Officer of ...
(Date:9/18/2014)... Columbia, SC (PRWEB) September 18, 2014 ... has just launched a new website which will make ... an accident in South Carolina to find helpful information ... office can provide to families of accident victims. , ... offers an improved mobile experience for today’s digital consumers. ...
Breaking Medicine News(10 mins):Health News:Oxnard All-on-4™ Dental Implants Expert To Speak Tomorrow at Prestigious Canadian Academy of Restorative 2Health News:Oxnard All-on-4™ Dental Implants Expert To Speak Tomorrow at Prestigious Canadian Academy of Restorative 3Health News:Oxnard All-on-4™ Dental Implants Expert To Speak Tomorrow at Prestigious Canadian Academy of Restorative 4Health News:Oxnard All-on-4™ Dental Implants Expert To Speak Tomorrow at Prestigious Canadian Academy of Restorative 5Health News:One Week Kitchens Taking Display to Bloomsburg Fair 2Health News:Discount Dental Plans Allow Consumers to Search Thousands of Local Dentists, Compare Savings and Discounts, and Download a Printable Membership Card 2Health News:CRA Awarded Managed Support Contract for Global Retailer 2Health News:Columbia Personal Injury Law Firm Announces Launch of Redesigned Website 2
... beset with administrative problems, experienced another upheaval. In a ... // Dr. Hart, the Director of the program for ... Dr Hart will still continue as a full-time surgeon ... ,The UC San Diego, disappointed with the manner in ...
... Sullivan, who is suffering from breast cancer is camping outside the ... Herceptin. She is trying to draw the // attention of the ... speak to the Welsh Health Minister Brian Gibbons only in public. ... force could do very little about it until she breaks a ...
... Food Standards Agency advertisement, for misleading public opinion ... investigation was ordered following the wrong projection that ... their hypertension by consuming less salt. ... stated that there was indeed a breach of ...
... affected about 50 000 people on France's Indian Ocean island ... cure. Though not fatal this extremely painful disease results in ... disease has been recorded as 45 000 new cases since ... epidemiologal cell is keeping track of the prevalence of this ...
... Doctors in England have stated that the proposed Government ... clinics to 48 hours cannot be achieved without a ... an improvement in the health care facilities has also ... raised, requesting the local health officials to invest the ...
... Healthcare of Canada has been warned of fines by the ... health services. Copeman Healthcare intends to establish clinics in Ottawa, ... will be charging a joining fee of $1,200, and another ... ,The medicare law of the state says a ...
Cached Medicine News:Health News:Government Advertisement Faces Criticism For Wrong Salt Claim 2
(Date:9/17/2014)... , September 17, 2014 ... GRC 17536, has shown positive data in a Phase ... diabetic neuropathy , Glenmark Pharmaceuticals ... Potential Ankyrin 1 (TRPA1) antagonist, GRC 17536 has shown ... controlled, multi-centre, proof of concept study conducted on 138 ...
(Date:9/17/2014)... , Sept. 17, 2014  Lightbeam Health ... Accountable Care Organization (Physician Direct ACO) to deploy ... physicians in providing better care while reducing costs. ... Physician Direct Accountable Care Organization is ... Services (OPNS). The OPNS mission is to be ...
(Date:9/17/2014)... According to a new market ... Memory Device, Display, & Microprocessor/MCU), by Application (Imaging, Medical ... Geography - Global Forecast to 2020", published by MarketsandMarkets, ... to reach $56.50 Billion by 2020, growing at a ... Browse 235 market data Tables and 71 Figures spread ...
Breaking Medicine Technology:Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 2Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 3Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 2Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 3Medical Electronics Market Worth $56.50 Billion by 2020 2Medical Electronics Market Worth $56.50 Billion by 2020 3Medical Electronics Market Worth $56.50 Billion by 2020 4
... Alliance Catheter Delivery System (CDS) ... stabilization of the Aescula LV ... has a patented coronary sinus ... and easy access to the ...
... PCS2 system is Haemonetics ... collection of plasma and ... the collection of "jumbo" ... platelet-poor plasma with optional ...
Optipress II Automated Blood Component Extractor for the standardized separation of whole blood into high purity individual components...
... Pipette* provides quick, convenient, repetitive dispensing ... Combitips have a polyethylene plunger and ... for use with most reagents. ... Five separate volumes can be selected ...
Medicine Products: